Core Viewpoint - The company, Jinhao Medical, has reported a stock price increase and has made a significant decision regarding the use of idle funds for investment in bank financial products, reflecting a strategic move to optimize asset management [1]. Group 1: Stock Performance - As of November 25, 2025, Jinhao Medical's stock closed at 31.13 yuan, marking a 0.81% increase from the previous trading day [1]. - The stock opened at 31.03 yuan, reached a high of 31.88 yuan, and a low of 30.81 yuan, with a trading volume of 20.1052 million yuan and a turnover rate of 1.16% [1]. Group 2: Shareholder Meeting - On November 20, 2025, Jinhao Medical held its third extraordinary general meeting of shareholders, where a proposal to use part of the idle self-owned funds to purchase bank financial products was approved [1]. - The meeting was attended by 5 shareholders, representing 61.0135% of the total voting shares, with 100% of the votes in favor and no opposition or abstentions [1]. - Guangdong Dongfang Kunlun (Dongguan) Law Firm witnessed the meeting and issued a legal opinion confirming the legality and compliance of the meeting's procedures and resolutions [1].
锦好医疗（920925）披露使用部分闲置自有资金购买银行理财产品公告，11月25日股价上涨0.81%